Detailed information for compound 1590951
Basic information
Technical information
- TDR Targets ID: 1590951
- Name: 7-Bromodibenzo[a,c]cycloocten-5(6H)-one
- MW: 299.162 | Formula: C16H11BrO
-
H donors: 0
H acceptors: 1
LogP: 4.2
Rotable bonds: 0
Rule of 5 violations (Lipinski): 1 - SMILES: BrC1=Cc2ccccc2c2c(C(=O)C1)cccc2
- InChi: 1S/C16H11BrO/c17-12-9-11-5-1-2-6-13(11)14-7-3-4-8-15(14)16(18)10-12/h1-9H,10H2/b12-9+
- InChiKey: WTBQKTXQSJRFSR-FMIVXFBMSA-N
Network
Hover on a compound node to display the structore
Synonyms
- AIDS-139096
- AIDS139096
- NSC647350
- NCI60_016413
Targets
Known targets for this compound
No curated genes were found associated with this compound
Predicted pathogen targets for this compound
By orthology
No druggable targets predicted by orthology data
By sequence similarity to non orthologous known druggable targets
No druggable targets predicted by sequence similarity
Obtained from network model
Ranking Plot
Putative Targets List
| Species | Potential target | Raw | Global | Species |
|---|---|---|---|---|
| Schistosoma mansoni | fatty-acid amide hydrolase | 0.0625 | 1 | 1 |
| Entamoeba histolytica | hydrolase, alpha/beta fold family domain containing protein | 0.0222 | 0.24 | 0.5 |
| Plasmodium vivax | PST-A protein | 0.0222 | 0.24 | 0.5 |
| Leishmania major | developmentally regulated phosphoprotein-like protein | 0.0272 | 0.3336 | 1 |
| Mycobacterium tuberculosis | Possible lysophospholipase | 0.0222 | 0.24 | 0.5 |
| Leishmania major | monoglyceride lipase, putative | 0.0222 | 0.24 | 0.7194 |
| Trypanosoma cruzi | monoglyceride lipase, putative | 0.0222 | 0.24 | 0.7194 |
| Trypanosoma brucei | monoglyceride lipase, putative | 0.0222 | 0.24 | 0.7194 |
| Trichomonas vaginalis | valacyclovir hydrolase, putative | 0.0222 | 0.24 | 0.5 |
| Trichomonas vaginalis | Clan SC, family S33, methylesterase-like serine peptidase | 0.0222 | 0.24 | 0.5 |
| Echinococcus granulosus | fatty acid amide hydrolase 1 | 0.0625 | 1 | 1 |
| Toxoplasma gondii | ATPase/histidine kinase/DNA gyrase B/HSP90 domain-containing protein | 0.011 | 0.0285 | 1 |
| Plasmodium falciparum | esterase, putative | 0.0222 | 0.24 | 0.5 |
| Plasmodium falciparum | lysophospholipase, putative | 0.0222 | 0.24 | 0.5 |
| Schistosoma mansoni | pyruvate dehydrogenase | 0.0272 | 0.3336 | 0.041 |
| Trichomonas vaginalis | conserved hypothetical protein | 0.0222 | 0.24 | 0.5 |
| Trypanosoma brucei | monoglyceride lipase, putative | 0.0222 | 0.24 | 0.7194 |
| Mycobacterium ulcerans | hypothetical protein | 0.0222 | 0.24 | 0.5 |
| Trichomonas vaginalis | Clan SC, family S33, methylesterase-like serine peptidase | 0.0222 | 0.24 | 0.5 |
| Mycobacterium leprae | POSSIBLE LYSOPHOSPHOLIPASE | 0.0222 | 0.24 | 0.5 |
| Loa Loa (eye worm) | hypothetical protein | 0.0625 | 1 | 1 |
| Echinococcus granulosus | fatty acid amide hydrolase 1 | 0.0625 | 1 | 1 |
| Trichomonas vaginalis | Clan SC, family S33, methylesterase-like serine peptidase | 0.0222 | 0.24 | 0.5 |
| Trichomonas vaginalis | Clan SC, family S33, methylesterase-like serine peptidase | 0.0222 | 0.24 | 0.5 |
| Trypanosoma brucei | developmentally regulated phosphoprotein | 0.0272 | 0.3336 | 1 |
| Trichomonas vaginalis | Clan SC, family S33, methylesterase-like serine peptidase | 0.0222 | 0.24 | 0.5 |
| Plasmodium falciparum | lysophospholipase, putative | 0.0222 | 0.24 | 0.5 |
| Mycobacterium ulcerans | lysophospholipase | 0.0222 | 0.24 | 0.5 |
| Echinococcus multilocularis | fatty acid amide hydrolase 1 | 0.0625 | 1 | 1 |
| Trypanosoma cruzi | developmentally regulated phosphoprotein, putative | 0.0272 | 0.3336 | 1 |
| Entamoeba histolytica | hydrolase, alpha/beta fold family domain containing protein | 0.0222 | 0.24 | 0.5 |
| Echinococcus multilocularis | fatty acid amide hydrolase 1 | 0.0625 | 1 | 1 |
| Trichomonas vaginalis | conserved hypothetical protein | 0.0222 | 0.24 | 0.5 |
| Schistosoma mansoni | amidase | 0.0625 | 1 | 1 |
| Plasmodium falciparum | lysophospholipase, putative | 0.0222 | 0.24 | 0.5 |
Activities
| Activity type | Activity value | Assay description | Source | Reference |
|---|---|---|---|---|
| GI50 (functional) | -5.767 | PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the HL-60(TB) Leukemia cell line. (Class of assay: confirmatory) | ChEMBL. | No reference |
| GI50 (functional) | -5.734 | PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the HOP-92 Non-Small Cell Lung cell line. (Class of assay: confirmatory) | ChEMBL. | No reference |
| GI50 (functional) | -5.719 | PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the ACHN Renal cell line. (Class of assay: confirmatory) | ChEMBL. | No reference |
| GI50 (functional) | -5.691 | PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the SN12C Renal cell line. (Class of assay: confirmatory) | ChEMBL. | No reference |
| GI50 (functional) | -5.665 | PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the SF-539 Central Nervous System cell line. (Class of assay: confirmatory) | ChEMBL. | No reference |
| GI50 (functional) | -5.665 | PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the MALME-3M Melanoma cell line. (Class of assay: confirmatory) | ChEMBL. | No reference |
| GI50 (functional) | -5.62 | PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the UO-31 Renal cell line. (Class of assay: confirmatory) | ChEMBL. | No reference |
| GI50 (functional) | -5.5 | PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the NCI-H23 Non-Small Cell Lung cell line. (Class of assay: confirmatory) | ChEMBL. | No reference |
| GI50 (functional) | -5.268 | PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the SK-MEL-5 Melanoma cell line. (Class of assay: confirmatory) | ChEMBL. | No reference |
Phenotypes
Whole-cell/tissue/organism interactions
We have no records of whole-cell/tissue assays done with this compound
What does this mean?
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
Annotated phenotypes:
We have no manually annotated phenotypes for this drug.
What does this mean? / Care to help?
In TDR Targets, information about phenotypes that are caused by
drugs, or by genetic manipulation of cells (e.g. gene knockouts or
knockdowns) is manually curated from the literature. These
descriptions help to describe the potential of the target for drug
development. If no information is available for this gene or if the
information is incomplete, this may mean that i) the papers
containing this information either appeared after the curation
effort for this organism was carried out or they were inadvertently
missed by curators; or that ii) the curation effort for this
organism has not yet started.
In any case, if you have information about papers containing relevant validation data for this target, please log in using your TDR Targets username and password and send them to us using the corresponding form in this page (only visible to registered users) or contact us.
In any case, if you have information about papers containing relevant validation data for this target, please log in using your TDR Targets username and password and send them to us using the corresponding form in this page (only visible to registered users) or contact us.
External resources for this compound
- ChEMBL: CHEMBL1977145
Bibliographic References
No literature references available for this target.
If you have references for this compound, please enter them in a user comment (below) or Contact us.